## ACT: Enact Holdings, Inc. - XLF: Financial Services

### Executive Summary

No thesis match: MRS_10 -1.0% below STRENGTH zone (3.0-6.0%); PEG unavailable fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($38.84)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 1
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Behavioral Patterns of ACT and Institutional Flows**
- Source: Stock Traders Daily | 20251229T195000 | Neutral | Relevance: 100%
- This article analyzes Enact Holdings Inc. (NYSE: ACT), highlighting a near-term neutral sentiment amidst mid and long-term strength. It presents exceptional risk-reward short setup opportunities and outlines three distinct AI-generated trading strategies tailored for different risk profiles and holding periods, including position trading, momentum breakout, and risk hedging strategies. The analysis also provides multi-timeframe signal insights for support and resistance levels.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-18 | Keefe, Bruyette | $43 | $42 | +2% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-18 | Keefe, Bruyette | main | Market Perform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 14 ($0.00M) |
| Sells | 4 ($67.23M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 13.0% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 2 |

**Top Holders:**
- Blackrock Inc.: 3.2% (+1.0%)
- Vanguard Group Inc: 2.2% (-2.0%)
- Dimensional Fund Adv: 1.9% (+7.1%)
- First Trust Advisors: 1.0% (+87.9%)
- Qube Research & Tech: 1.0% (+289.4%)

### Key Risks

1. Heavy insider selling: $67M sold (4 transactions in 90 days).
2. High short interest (15.7%, 12.3 days to cover): squeeze risk or crowded bearish bet.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

Forward P/E 8.6x stretched relative to 4% growth. Quality metrics strong (margin 54%). Balance sheet: strong liquidity (6612078000.0x), low leverage (D/E 0.29). Insider selling cluster ($67.2M in 90 days), potential headwind. Institutional flow bullish (7 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $5.9B |
| Beta | 0.52 |
| 52W Range | $30.79 - $40.88 |
| Short Interest | 15.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | N/A |
| Forward P/E | 8.6 |
| Current P/E | 8.9 |
| YoY Growth | 3.9% |
| EPS Direction | STABLE |

### Technicals

MRS_10 weakening modestly (-0.6% over 5 days). Below STRENGTH zone by 4.0pp (needs >3.0% for momentum thesis). MRS_5 turning positive (0.1%) - potential reversal signal. Full SMA alignment bullish (above 20/50/200 SMAs). OFD pattern: +DBL (Indecision).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -0.98% (CS: 31) | Neutral |
| RSI_14 | 60.5 | Neutral |
| MACD Histogram | -0.05 | Bearish |
| vs SMA20 | 1.014x | Above |
| vs SMA50 | 1.053x | Above |
| vs SMA200 | 1.094x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $40.04
- **Stop Loss:** $38.84 (3.0% risk)
- **Target:** $41.24 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 687
- **Position Value:** $27,507.48
- **Portfolio %:** 27.51%
- **Risk Dollars:** $825.00
- **Risk Per Trade:** 0.83%
- **Modifiers:** L1 110% | L2 75% | Combined 0.83x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.10x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with balanced risk signals and moderate market participation. VIX at 14.33 indicates calm conditions, while positive yield curve (+59bps) and stable economic data support continued expansion. Year-end positioning and Fed uncertainty create near-term caution, but no systemic risks evident.*

### Earnings

**Next:** 2026-02-04 (Est: $1.10)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.11 | $1.12 | +0.9% |
| 2025Q2 | $1.11 | $1.15 | +3.9% |
| 2025Q1 | $1.09 | $1.10 | +0.9% |
| 2024Q4 | $1.08 | $1.09 | +0.7% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*